2941-17-5Relevant articles and documents
NON-SYSTEMIC TGR5 AGONISTS
-
Page/Page column 123; 124, (2013/07/05)
Compounds of structure (I), or a stereoisomer, tautomer, pharmaceutically acceptable salt or prodrug thereof, wherein R1, R2, R3, R4, R8, R9, R10, R11, R12, A1, A2, X, Y and Z are as defined herein. Uses of such compounds as TGR5 antagonists and for treatment of various indications, including Type II diabetes meletus are also provided.
Converting gem-dimethyl groups into cyclopropanes via Pd-catalyzed sequential C-H activation and radical cyclization
Giri, Ramesh,Wasa, Masayuki,Breazzano, Steven P.,Yu, Jin-Quan
, p. 5685 - 5688 (2007/10/03)
(Diagram presented) A novel route to the synthesis of cyclopropane derivatives is described. 1,1-Dimethyls in 2-(1,1-dimethylalkyl) dimethyloxazolines are first converted into 1,3-diiodide derivatives via Pd-catalyzed sequential C-H activation and then radically cyclized to provide 2-(1-alkylcylclopropyl)-dimethyloxazolines. The use of EtOAc as a solvent is crucial for the diiodination of the functionalized substrates.
1,5-DIAZABICYCLO-(3.3.0)-OCTANE-2,6-DIONES AND DERIVATIVES.
BELLASIO,PAGANI,RIPAMONTI,TESTA
, p. 428 - 445 (2007/10/05)
-